With heightened awareness about mitigating the spread of pathogens due to the pandemic, the surface coating market is expected to experience substantial growth. It is projected to reach a value of $3.5 billion by 2025, a significant increase from $1.3 billion in 2020. FendX Technologies (Ticker: FNDX.c), a recently listed company, offers innovative surface coating solutions powered by its proprietary nanotechnology, positioning itself as a unique and promising player in the industry.
FNDX's flagship product, REPELWRAP™, is an innovative surface coating that utilizes nanotechnology to repel pathogens to prevent their transmission.
Testing has demonstrated that REPELWRAP™ is highly effective against multiple strains of Covid-19, reducing viral titers by over 99%. It also significantly reduces the transfer of e coli by 20-fold. Moreover, REPELWRAP™ has been shown to decrease colony formation of strains of Staphylococcus and Pseudomonas by more than 85%.
The first product FNDX plans to bring to market is REPELWRAP™ film. This film can adhere to surfaces which are prone to contamination. This makes it highly valuable in healthcare settings and other environments where maintaining strict infection control is critical.
Dr. Carolyn Myers, CEO of FNDX, recently did a brief interview which is packed full of information on:
- FNDX's technology
- Her and her team's expertise and experience
- How FNDX is transferring REPELWRAP™ film to the company's manufacturer for scale-up
- Additional products that FNDX is starting to develop
- FNDX's reasons for listing on the CSE
- & more
Watch the interview here:
Posted on behalf of FendX Technologies Inc.